102sek
-2,1 %
Date:2024-04-19Time:17:29:30Latest report:Q4-2023List:Small CapTicker:ATORX
Market Cap:773 msekEnterprise Value:723 msekNet Sales:58,1 msekEarnings:-248,6 msekEmployees:0ISIN:SE0000767188

Ratios

10-year key figure history for Alligator Bioscience turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Alligator Bioscience with index and moving average MA50 and MA200.

Stockprice:1,02
MA50:1,04
MA200:0,68
Price/MA200:49,5 %
RSI (14):49,4
Price/MA50:-2,6 %

Description

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Biotechnology